Ubs Asset Management Americas Inc Treace Medical Concepts, Inc. Transaction History
Ubs Asset Management Americas Inc
- $345 Billion
- Q2 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 132,869 shares of TMCI stock, worth $718,821. This represents 0.0% of its overall portfolio holdings.
Number of Shares
132,869
Previous 35,877
270.35%
Holding current value
$718,821
Previous $468,000
88.68%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TMCI
# of Institutions
129Shares Held
39.5MCall Options Held
272KPut Options Held
261K-
Armistice Capital, LLC New York, NY5.36MShares$29 Million0.46% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$22 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.68MShares$19.9 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.62MShares$19.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.83MShares$15.3 Million0.0% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $300M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...